Try our beta test site
71 studies found for:    Open Studies | "Bone Diseases, Infectious"
Show Display Options
Rank Status Study
21 Not yet recruiting Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis
Condition: AS
Interventions: Drug: IBI303;   Drug: Adalimumab
22 Not yet recruiting Protection of Autonomic Nervous System During Lower Spine Surgical Procedures: A Safety and Feasibility Study
Conditions: Intervertebral Disc Degeneration;   Intervertebral Disc Displacement;   Spinal Curvatures;   Spinal Stenosis;   Spondylitis;   Spondylosis;   Osteoarthropathy, Primary Hypertrophic;   Spinal Neoplasms
Intervention: Device: Autonomic nervous system monitoring
23 Recruiting Ankylosing Spondylitis and Antiphospholipid Antibodies
Condition: Ankylosing Spondylarthritis
Intervention: Biological: blood collection
24 Not yet recruiting Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: BCD-085;   Other: Placebo
25 Recruiting A Randomized, Double-blind, Placebo-controlled Multicenter Study of Secukinumab (AIN457) to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: AIN457/Secukinumab;   Drug: AIN457/Secukinumab Placebo
26 Recruiting Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: BCD-055;   Biological: Remicade®
27 Recruiting The Effect of NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in the Spine in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: Golimumab;   Drug: Celecoxib
28 Recruiting Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: secukinumab 150mg
29 Recruiting Electroacupuncture for Relieving Pain in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Device: Electroacupuncture
30 Recruiting Does Immunogenicity Have an Influence on the Efficacy of Anti-TNF Therapy in Patients With AS: An Inception Cohort Study
Conditions: Ankylosing Spondylitis;   Axial Spondyloarthritis
Intervention:
31 Not yet recruiting A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: ENIA11;   Biological: Placebo
32 Recruiting WEB-Based Physiotherapy for People With Axial Spondyloarthritis
Condition: Ankylosing Spondylitis
Intervention: Behavioral: Exercise
33 Not yet recruiting Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: etanercept (Half-Dose);   Drug: etanercept (Full-Dose);   Drug: Sulfasalazine;   Drug: Celecoxib
34 Recruiting An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention:
35 Recruiting Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA
Condition: Spondylitis, Ankylosing
Intervention: Biological: Etanercept
36 Recruiting Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo
Conditions: Axial Spondyloarthrithis;   Ankylosing Spondylitis
Interventions: Biological: Certolizumab Pegol;   Other: Placebo
37 Recruiting Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients
Condition: Ankylosing Spondylitis
Intervention: Drug: Adalimumab
38 Recruiting Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes
Condition: Ankylosing Spondylitis
Interventions: Drug: NSAIDs;   Drug: anti-TNF
39 Recruiting Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: TNF alpha;   Drug: NSAIDs and sulfasalazine
40 Recruiting An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis
Condition: Nonradiographic Axial Spondylitis, Ankylosing
Interventions: Drug: Group 1: Placebo;   Drug: Group 2: Ustekinumab 45 mg;   Drug: Group 3: Ustekinumab 90 mg

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.